None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Men and women over 60 years old 2) Dementia patient diagnosed by DSM-IV and used acetylcholine esterase inhibitor 3) Over 20 in K-MMSE, 0.5~1 in CDR or 3~4 in GDS (over 3 in CDR-SB in the case of CDR 0.5) 4) Patient with ability and willingness of consent of this study 5) Patient with ability of using smart drug kit
Exclusion criteria
Exclusion criteria: 1) Patient refused to ICT-based centralized monitoring system 2) Patient is not allowed to scheduled visit during period of study 3) Patient unable scheduled examination owing to severe aphasia, severe hearing or visual impairment 4) hospitalized patient 5) A person who is unfit to participate this study for another reason
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| drug compliance | — |
Secondary
| Measure | Time frame |
|---|---|
| cognitive function change;test group satisfaction | — |
Countries
Korea, Republic of
Contacts
Daegu Fatima Hospital